OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women (OCP)
Primary Purpose
Polycystic Ovary Syndrome
Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate
Metformin 1500mgs per day
Sponsored by
About this trial
This is an interventional treatment trial for Polycystic Ovary Syndrome focused on measuring PCOS, Metformin, OCP, metabolic parameters
Eligibility Criteria
Inclusion Criteria:
- PCOS Women diagnosed by Rotterdam criteria
- Age > 16 or menarche of at least 2 yr upto age 40.
- Diagnosed by Rotterdam Anovulation F.G. Score ≥ 8 or Total testosterone ≥ 40 ngms/dl ovarian volume ≥ 10 cc BMI>23
- Women not attempting pregnancy at present.
Exclusion Criteria:
- PCOS Women with BMI ≤ 23
- Undergoing any treatment for acne hirsutism. Including Homeopathic, Ayurvedic
- Known diabetic or hypertension .
Sites / Locations
- KAR clinic and hospital pvt ltdRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
OCP
Metformin
Arm Description
Arm 1: oral contraceptive pill, combination pill of ethyl estradiol 20 micro gram with Cyproterone acetate.
Arm 2: Metformin . Oral insulin sensitising drug in the dose of 1500gms daily.
Outcomes
Primary Outcome Measures
Improvements in Menstrual cycle in women with polycystic ovary syndrome.
To compare improvement in Menstrual cycle. Women will be required to maintain a menstrual calendar for the duration of the study and asked to fill a questionnaire before and after study duration.The questionnaire will cover menstrual cycle dates, duration and amount. Interpreting the answered will help in assessing improvement in menstrual pattern.
Improvement in hirsutism
FG scores before and after treatment will be compared between the two arms. Modified Ferriman and Gallwey visual score will be used by a nurse to assess before and after the study period.
Improvement in acne score
Acne scores before and after treatment will be compared between the two arms. Visual assessment of acne using "mild/moderate/severe " grades will be assessed before and after study by a physician.
Weight loss following treatment
Weight loss will be compared between the two arms following 6 months of treatment
Reduction in total testosterones
Reduction in total testosterones, signifying biochemical hyperandrogenemia, will be compared between the two groups following 6 months treatment.
Reduction in serum fasting insulin
Reduction in insulin levels following treatment will be compared between the two arms
Improvements in lipid profile
Any improvement in triglycerides and HDLc (high density lipoprotein c) will be compared between the two groups after 6 months of treatment
Improvement in glucose tolerance
75grams 2 hour glucose challenge test results will be compared pre and post treatment between the two groups
Secondary Outcome Measures
Full Information
NCT ID
NCT02744131
First Posted
March 20, 2016
Last Updated
February 1, 2018
Sponsor
Kar Clinic & Hospital Pvt. Ltd.
Collaborators
All India Institute of Medical Sciences, New Delhi, Nova IVI Fertility, New Delhi, Dr Patil's Fertility & Endoscopy Clinic, Bangalore, Shreyas Hospital & Sushrut Assisted Conception Clinic, Kolhapur, University of Messina
1. Study Identification
Unique Protocol Identification Number
NCT02744131
Brief Title
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
Acronym
OCP
Official Title
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
September 2018 (Anticipated)
Study Completion Date
December 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kar Clinic & Hospital Pvt. Ltd.
Collaborators
All India Institute of Medical Sciences, New Delhi, Nova IVI Fertility, New Delhi, Dr Patil's Fertility & Endoscopy Clinic, Bangalore, Shreyas Hospital & Sushrut Assisted Conception Clinic, Kolhapur, University of Messina
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Objective: To assess effectiveness of ISD (Insulin sensitizing drugs) Vs OCP (Combined E&P cyproterone acetate) in improving clinical, hormonal and metabolic features of PCOS( polycystic ovary syndrome)women from India.
Intervention:
Randomized to receive Metformin 1500 mg / day OR OCP (EE+CA) Life style advice to women with BMI ( body mass index) more than 28 , in both groups (PS: progesterone can be added for getting withdrawal bleeding for amenorrhoea of more than two months, or for prolonged menstrual bleeding. ) Study period: 6 months Clinical evaluation points and tests at enrollment and again after 6 month. Clinical: BMI, Waist circumference, Hip circumference, Acne score, FG (modified Ferriman Gallwey score ) (after no epilation for last 6 weeks), Menstrual History Biochemical: Thyroid function tests, Prolactin,Total Testosterone, Lipid Profile, FAsting blood sugar & 75 gm 2 hr Glucose tolerance test (GTT), Sr Insulin, 25- hydroxy vitamin D (optional), (Only Radioimmunoassay / Chemiluminescence assays)
Acronyms: OCP(oral contraceptive pills); PCOS (polycystic ovary syndrome); FBS(fasting blood sugar); GTT(glucose tolerance test)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polycystic Ovary Syndrome
Keywords
PCOS, Metformin, OCP, metabolic parameters
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
OCP
Arm Type
Active Comparator
Arm Description
Arm 1: oral contraceptive pill, combination pill of ethyl estradiol 20 micro gram with Cyproterone acetate.
Arm Title
Metformin
Arm Type
Active Comparator
Arm Description
Arm 2: Metformin . Oral insulin sensitising drug in the dose of 1500gms daily.
Intervention Type
Drug
Intervention Name(s)
Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate
Intervention Type
Drug
Intervention Name(s)
Metformin 1500mgs per day
Primary Outcome Measure Information:
Title
Improvements in Menstrual cycle in women with polycystic ovary syndrome.
Description
To compare improvement in Menstrual cycle. Women will be required to maintain a menstrual calendar for the duration of the study and asked to fill a questionnaire before and after study duration.The questionnaire will cover menstrual cycle dates, duration and amount. Interpreting the answered will help in assessing improvement in menstrual pattern.
Time Frame
Six months
Title
Improvement in hirsutism
Description
FG scores before and after treatment will be compared between the two arms. Modified Ferriman and Gallwey visual score will be used by a nurse to assess before and after the study period.
Time Frame
six months
Title
Improvement in acne score
Description
Acne scores before and after treatment will be compared between the two arms. Visual assessment of acne using "mild/moderate/severe " grades will be assessed before and after study by a physician.
Time Frame
Six months
Title
Weight loss following treatment
Description
Weight loss will be compared between the two arms following 6 months of treatment
Time Frame
6months
Title
Reduction in total testosterones
Description
Reduction in total testosterones, signifying biochemical hyperandrogenemia, will be compared between the two groups following 6 months treatment.
Time Frame
6months
Title
Reduction in serum fasting insulin
Description
Reduction in insulin levels following treatment will be compared between the two arms
Time Frame
6 months
Title
Improvements in lipid profile
Description
Any improvement in triglycerides and HDLc (high density lipoprotein c) will be compared between the two groups after 6 months of treatment
Time Frame
6months
Title
Improvement in glucose tolerance
Description
75grams 2 hour glucose challenge test results will be compared pre and post treatment between the two groups
Time Frame
6months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
PCOS Women diagnosed by Rotterdam criteria
Age > 16 or menarche of at least 2 yr upto age 40.
Diagnosed by Rotterdam Anovulation F.G. Score ≥ 8 or Total testosterone ≥ 40 ngms/dl ovarian volume ≥ 10 cc BMI>23
Women not attempting pregnancy at present.
Exclusion Criteria:
PCOS Women with BMI ≤ 23
Undergoing any treatment for acne hirsutism. Including Homeopathic, Ayurvedic
Known diabetic or hypertension .
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sujata Kar, MD
Phone
919437824163
Email
suju2463@gmail.com
Facility Information:
Facility Name
KAR clinic and hospital pvt ltd
City
Bhubaneswar
State/Province
Odisha
ZIP/Postal Code
751001
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sujata Kar, M.D
Phone
+919437824163
Email
suju2463@gmail.com
First Name & Middle Initial & Last Name & Degree
Suneeta Panigrahi, B.A
Email
womenwing@karhospitals.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
23531705
Citation
Kar S. Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial. J Hum Reprod Sci. 2012 Sep;5(3):262-5. doi: 10.4103/0974-1208.106338.
Results Reference
background
PubMed Identifier
26752854
Citation
Kar S, Sanchita S. Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial. J Hum Reprod Sci. 2015 Oct-Dec;8(4):197-201. doi: 10.4103/0974-1208.170373.
Results Reference
background
PubMed Identifier
23869152
Citation
Kumar P, Nawani N, Malhotra N, Malhotra J, Patil M, Jayakrishnan K, Kar S, Jirge PR, Mahajan N. Assisted reproduction in polycystic ovarian disease: A multicentric trial in India. J Hum Reprod Sci. 2013 Jan;6(1):49-53. doi: 10.4103/0974-1208.112382.
Results Reference
background
Learn more about this trial
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
We'll reach out to this number within 24 hrs